{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:33:02Z","timestamp":1790652782933,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.alit.2022.02.001","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T21:57:34Z","timestamp":1645653454000},"page":"179-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Drug allergy and autoimmune diseases"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0598-856X","authenticated-orcid":false,"given":"Yuko","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0297-6627","authenticated-orcid":false,"given":"Yukie","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2022.02.001_bib1","first-page":"1","article-title":"Zur Kenntnis der keratoconjunctivitis sicca. Keratitis filiformis bei Hypofunktion der Tr\u00e4nendr\u00fcsen [On knowledge of keratoconjunctivitis sicca. Keratitis filiformis due to lacrimal gland hypofunction]","volume":"2","author":"Henrik","year":"1933","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.alit.2022.02.001_bib2","doi-asserted-by":"crossref","first-page":"17368","DOI":"10.1002\/jcb.29001","article-title":"Identification of differentially expressed genes in primary Sj\u00f6gren's syndrome","volume":"120","author":"Zhang","year":"2019","journal-title":"J\u00a0Cel Biochem"},{"key":"10.1016\/j.alit.2022.02.001_bib3","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1742-1241.2008.01749.x","article-title":"Prevalence of primary Sjogren's syndrome in Turkey: a population-based epidemiological study","volume":"63","author":"Birlik","year":"2009","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.alit.2022.02.001_bib4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/ard.28.6.607","article-title":"Penicillin allergy in rheumatoid arthritis. With special reference to Sjogren's syndrome","volume":"28","author":"Williams","year":"1969","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.alit.2022.02.001_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1398-9995.1981.tb01829.x","article-title":"Sj\u00f6gren's syndrome. A review with emphasis on immunological features","volume":"36","author":"Manthorpe","year":"1981","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2022.02.001_bib6","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1136\/bmj.2.6099.1386","article-title":"Sj\u00f6gren's syndrome: a contraindication to levamisole treatment?","volume":"2","author":"Balint","year":"1977","journal-title":"Br Med J"},{"key":"10.1016\/j.alit.2022.02.001_bib7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00005792-199211000-00005","article-title":"Sj\u00f6gren's syndrome. A clinical, pathological, and serological study of sixty-two cases 1965","volume":"71","author":"Bloch","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.alit.2022.02.001_bib8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0140-6736(91)92202-D","article-title":"Drug allergy in Sj\u00f6gren's syndrome","volume":"337","author":"Katz","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2022.02.001_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/03009749950154220","article-title":"Adverse drug reactions in Sj\u00f6gren's syndrome. Frequent allergic reactions and a specific trimethoprim-associated systemic reaction","volume":"28","author":"Antonen","year":"1999","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.alit.2022.02.001_bib10","first-page":"213","article-title":"[Collagen disease and drug allergy]","volume":"7","author":"Nakao","year":"1988","journal-title":"Kyusyu Riumachi"},{"key":"10.1016\/j.alit.2022.02.001_bib11","first-page":"717","article-title":"[Clinical studies of skin manifestation of Sjogren\u2019s syndrome]","volume":"99","author":"Katayama","year":"1989","journal-title":"[Jpn J Dermatol]"},{"key":"10.1016\/j.alit.2022.02.001_bib12","first-page":"371","article-title":"[Allergic disorders in primary Sjogren syndrome]","volume":"51","author":"Aoki","year":"2002","journal-title":"Arerugi"},{"key":"10.1016\/j.alit.2022.02.001_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jdermsci.2020.09.009","article-title":"The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016-2018","volume":"100","author":"Sunaga","year":"2020","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.alit.2022.02.001_bib14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(85)92146-4","article-title":"Sj\u00f6gren-like syndrome after drug-induced toxic epidermal necrolysis","volume":"1","author":"Roujeau","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2022.02.001_bib15","first-page":"531","article-title":"Syndrome de Stevens-Johnson suivi d'un syndrome de Gougerot-Sj\u00f6gren [Stevens-Johnson syndrome followed by Gougerot-Sj\u00f6gren syndrome]","volume":"30","author":"de Roux Serratrice","year":"2001","journal-title":"Presse Med"},{"key":"10.1016\/j.alit.2022.02.001_bib16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1600-0560.1995.tb01420.x","article-title":"Toxic epidermal necrolysis. A study of the sweat glands","volume":"22","author":"Akosa","year":"1995","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.alit.2022.02.001_bib17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2340\/00015555-2295","article-title":"Long-term sequelae of Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"96","author":"Yang","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.alit.2022.02.001_bib18","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/030097498440769","article-title":"Allergic disorders in primary Sj\u00f6gren's syndrome","volume":"27","author":"Tishler","year":"1998","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.alit.2022.02.001_bib19","first-page":"1040","article-title":"Anti-Ro (SSA) antibodies in patients with rheumatoid arthritis--a possible marker for gold induced side effects","volume":"21","author":"Tishler","year":"1994","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.alit.2022.02.001_bib20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s002960050023","article-title":"Anti-Ro (SSA) antibodies in rheumatoid arthritis patients with gold-induced side effects","volume":"17","author":"Tishler","year":"1997","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.alit.2022.02.001_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0049-0172(73)90034-6","article-title":"The epidemiology of systemic lupus erythematosus","volume":"3","author":"Siegel","year":"1973","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.alit.2022.02.001_bib22","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/archinte.1974.00320240061006","article-title":"Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women","volume":"134","author":"Fessel","year":"1974","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.alit.2022.02.001_bib23","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/rheumatology\/32.2.110","article-title":"The prevalence and incidence of systemic lupus erythematosus in Nottingham, UK, 1989\u20131990","volume":"32","author":"Hopkinson","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.alit.2022.02.001_bib24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/096120339700600204","article-title":"Epidemiology and socioeconomic impact of skin disease in lupus erythematosus","volume":"6","author":"Tebbe","year":"1997","journal-title":"Lupus"},{"key":"10.1016\/j.alit.2022.02.001_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/096120339300200311","article-title":"Allergic disorders in systemic lupus erythematosus","volume":"2","author":"Sequeira","year":"1993","journal-title":"Lupus"},{"key":"10.1016\/j.alit.2022.02.001_bib26","first-page":"265","article-title":"Antibiotic allergy in systemic lupus erythematosus: a case-control study","volume":"19","author":"Petri","year":"1992","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.alit.2022.02.001_bib27","first-page":"480","article-title":"Frequency of adverse drug reactions in patients with systemic lupus erythematosus","volume":"30","author":"Pope","year":"2003","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.alit.2022.02.001_bib28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/RHU.0b013e31817a241a","article-title":"Drug allergies may be more frequent in systemic lupus erythematosus than in rheumatoid arthritis","volume":"14","author":"Aceves-Avila","year":"2008","journal-title":"J\u00a0Clin Rheumatol"},{"key":"10.1016\/j.alit.2022.02.001_bib29","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3390\/diagnostics10110918","article-title":"Prevalence and impact of reported drug allergies among Rheumatology patients","volume":"10","author":"Chan","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"2 Suppl 2","key":"10.1016\/j.alit.2022.02.001_bib30","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/j.jaci.2009.10.028","article-title":"Drug allergy","volume":"125","author":"Khan","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2022.02.001_bib31","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.anai.2018.11.014","article-title":"Drug allergy in children and adults: is it the double X chromosome?","volume":"122","author":"Eaddy Norton","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.alit.2022.02.001_bib32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/ard.30.2.121","article-title":"Still's disease in the adult","volume":"30","author":"Bywaters","year":"1971","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.alit.2022.02.001_bib33","first-page":"1055","article-title":"Adult-onset Still's disease; clinical and laboratory features, treatment and progress of 45 cases","volume":"61","author":"Wouters","year":"1986","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.alit.2022.02.001_bib34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/art.1780290316","article-title":"Adult-onset Still's disease. Disease course and HLA associations","volume":"29","author":"Wouters","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.alit.2022.02.001_bib35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult Still's disease: manifestations, disease course, and outcome in 62 patients","volume":"70","author":"Pouchot","year":"1991","journal-title":"Medicine"},{"key":"10.1016\/j.alit.2022.02.001_bib36","first-page":"489","article-title":"Association between HLA-DR B1 and clinical features of adult onset Still's disease in Korea","volume":"21","author":"Joung","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.alit.2022.02.001_bib37","first-page":"1058","article-title":"Adult Still's disease: a multicenter survey of Japanese patients","volume":"17","author":"Ohta","year":"1990","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.alit.2022.02.001_bib38","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/14397595.2014.974881","article-title":"Nationwide epidemiological survey of 169 patients with adult Still's disease in Japan","volume":"25","author":"Asanuma","year":"2015","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.alit.2022.02.001_bib39","first-page":"965","article-title":"[Allergic diseases in adult-onset Still\u2019s disease and rheumatoid arthritis]","volume":"70","author":"Higashida-Konishi","year":"2021","journal-title":"Arerugi"},{"key":"10.1016\/j.alit.2022.02.001_bib40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13075-017-1406-x","article-title":"Effects of HLA-DRB1 alleles on susceptibility and clinical manifestations in Japanese patients with adult onset Still's disease","volume":"19","author":"Asano","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.alit.2022.02.001_bib41","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3109\/0284186X.2011.640347","article-title":"Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1\u22171501 and HLA-DQB1\u22170602","volume":"51","author":"Penna","year":"2012","journal-title":"Acta Oncol"},{"key":"10.1016\/j.alit.2022.02.001_bib42","doi-asserted-by":"crossref","first-page":"e68111","DOI":"10.1371\/journal.pone.0068111","article-title":"HLA alleles influence the clinical signature of amoxicillin-clavulanate hepatotoxicity","volume":"8","author":"Stephens","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.alit.2022.02.001_bib43","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1093\/rheumatology\/kew300","article-title":"Elevated serum levels of free interleukin-18 in adult-onset Still's disease","volume":"55","author":"Girard","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.alit.2022.02.001_bib44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41927-019-0053-z","article-title":"Comparative study of Interleukin-18 (IL-18) serum levels in adult onset Still's disease (AOSD) and systemic onset juvenile idiopathic arthritis (sJIA) and its use as a biomarker for diagnosis and evaluation of disease activity","volume":"3","author":"Kudela","year":"2019","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.alit.2022.02.001_bib45","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/03009742.2013.824023","article-title":"Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease","volume":"43","author":"Jung","year":"2014","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.alit.2022.02.001_bib46","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3899\/jrheum.120079","article-title":"Serum S100A8\/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease","volume":"39","author":"Kim","year":"2012","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.alit.2022.02.001_bib47","doi-asserted-by":"crossref","first-page":"488","DOI":"10.5649\/jjphcs.33.488","article-title":"[Study on drugs with risk of producing severe cutaneous reactions and risk factors involved]","volume":"33","author":"Hayakawa","year":"2007","journal-title":"[Jpn J Pharm Health Care Sci]"},{"key":"10.1016\/j.alit.2022.02.001_bib48","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.jid.2018.04.027","article-title":"Stevens-Johnson syndrome\/toxic epidermal necrolysis: a multicenter retrospective study of 377 adult patients from the United States","volume":"138","author":"Micheletti","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2022.02.001_bib49","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.4103\/0366-6999.204929","article-title":"Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 88 Chinese patients","volume":"130","author":"Wang","year":"2017","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.alit.2022.02.001_bib50","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0190-9622(87)80031-2","article-title":"Lupus erythematosus and toxic epidermal necrolysis","volume":"16","author":"Bielsa","year":"1987","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.alit.2022.02.001_bib51","series-title":"Skin Signs of Systemic Disease","first-page":"213","article-title":"Connective tissue (rheumatic) diseases","author":"Braverman","year":"1998"},{"key":"10.1016\/j.alit.2022.02.001_bib52","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1067\/mjd.2003.107","article-title":"Lupus-associated toxic epidermal necrolysis: a novel manifestation of lupus?","volume":"48","author":"Mandelcorn","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.alit.2022.02.001_bib53","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2230.2004.01498.x","article-title":"Bullous subacute cutaneous lupus erythematosus","volume":"29","author":"Perera","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.alit.2022.02.001_bib54","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1067\/mjd.2003.244","article-title":"Severe subacute cutaneous lupus erythematosus presenting with generalized erythroderma and bullae","volume":"48","author":"Mutasim","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.alit.2022.02.001_bib55","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1191\/0961203304lu2037sa","volume":"13","author":"Ting","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.alit.2022.02.001_bib56","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/0961203307079498","article-title":"Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus","volume":"16","author":"Paradela","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.alit.2022.02.001_bib57","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/0961203308089341","article-title":"Efficacy of plasmapheresis in the treatment of refractory toxic epidermal necrolysis-like acute cutaneous lupus erythematosus","volume":"17","author":"Simsek","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.alit.2022.02.001_bib58","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2133.2011.10705.x","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literature","volume":"166","author":"Ziemer","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2022.02.001_bib59","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s00296-020-04617-1","article-title":"Burn center admissions of patients with autoimmune rheumatic diseases: clinical characteristics and outcomes","volume":"40","author":"Parperis","year":"2020","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.alit.2022.02.001_bib60","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1177\/0961203311408377","article-title":"Stevens-Johnson syndrome in a juvenile systemic lupus erythematosus patient","volume":"20","author":"Cavalcante","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.alit.2022.02.001_bib61","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/bjd.20775","article-title":"Lupus erythematosus and epidermal necrolysis: a case series of 16 patients","volume":"186","author":"Gaudin","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2022.02.001_bib62","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.4049\/jimmunol.0804002","article-title":"Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome","volume":"182","author":"Takahashi","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.alit.2022.02.001_bib63","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3899\/jrheum.181232","article-title":"Neutrophil extracellular traps profiles in patients with incident systemic lupus erythematosus and lupus nephritis","volume":"47","author":"Bruschi","year":"2020","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.alit.2022.02.001_bib64","doi-asserted-by":"crossref","first-page":"614829","DOI":"10.3389\/fmed.2021.614829","article-title":"Neutrophil extracellular traps in the autoimmunity context","volume":"8","author":"Bruschi","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.alit.2022.02.001_bib65","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.4049\/jimmunol.1102404","article-title":"Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease","volume":"188","author":"Leffler","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.alit.2022.02.001_bib66","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/ar4264","article-title":"Degradation of neutrophil extracellular traps co-varies with disease activity in patients with systemic lupus erythematosus","volume":"15","author":"Leffler","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.alit.2022.02.001_bib67","doi-asserted-by":"crossref","first-page":"9813","DOI":"10.1073\/pnas.0909927107","article-title":"Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis","volume":"107","author":"Hakkim","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.alit.2022.02.001_bib68","doi-asserted-by":"crossref","first-page":"eaax2398","DOI":"10.1126\/scitranslmed.aax2398","article-title":"Neutrophils initiate and exacerbate Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"13","author":"Kinoshita","year":"2021","journal-title":"Sci Transl Med"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893022000065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893022000065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:12:54Z","timestamp":1761156774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893022000065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1323893022000065"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2022.02.001","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug allergy and autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2022.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese Society of Allergology. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}